BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

584 related articles for article (PubMed ID: 33599784)

  • 21. Primary aldosteronism: diagnostic and treatment strategies.
    Mattsson C; Young WF
    Nat Clin Pract Nephrol; 2006 Apr; 2(4):198-208; quiz, 1 p following 230. PubMed ID: 16932426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Personalized Treatment of Patients With Primary Aldosteronism.
    Obeid H; Chen Cardenas SM; Khairi S; Turcu AF
    Endocr Pract; 2023 Jun; 29(6):484-490. PubMed ID: 36273684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Primary aldosteronism: new insights into familial forms].
    van den Meiracker AH; van der Linde AA; Claahsen van der Grinten HL; Danser AH; Deinum J
    Ned Tijdschr Geneeskd; 2015; 159():A8932. PubMed ID: 26420144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary aldosteronism: challenges in diagnosis and management.
    Galati SJ
    Endocrinol Metab Clin North Am; 2015 Jun; 44(2):355-69. PubMed ID: 26038205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The difficulties in differential diagnosis of primary aldosteronism subtypes in women with strokes at a young age].
    Bohdanowicz-Pawlak A; Szymczak J; Jakubowska J; Brona A
    Endokrynol Pol; 2009; 60(6):492-6. PubMed ID: 20041369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mineralocorticoid Receptor Antagonist Effect on Aldosterone to Renin Ratio in Patients With Primary Aldosteronism.
    Pecori A; Buffolo F; Burrello J; Mengozzi G; Rumbolo F; Avataneo V; D'Avolio A; Rabbia F; Bertello C; Veglio F; Mulatero P; Monticone S
    J Clin Endocrinol Metab; 2021 Aug; 106(9):e3655-e3664. PubMed ID: 33942084
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence, diagnosis and outcomes of treatment for primary aldosteronism.
    Yang Y; Reincke M; Williams TA
    Best Pract Res Clin Endocrinol Metab; 2020 Mar; 34(2):101365. PubMed ID: 31837980
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MANAGEMENT OF ENDOCRINE DISEASE: Diagnosis and management of primary aldosteronism: the Endocrine Society guideline 2016 revisited.
    Williams TA; Reincke M
    Eur J Endocrinol; 2018 Jul; 179(1):R19-R29. PubMed ID: 29674485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Timeline of Advances in Genetics of Primary Aldosteronism.
    Meyer LS; Reincke M; Williams TA
    Exp Suppl; 2019; 111():213-243. PubMed ID: 31588534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetics of primary hyperaldosteronism.
    Dutta RK; Söderkvist P; Gimm O
    Endocr Relat Cancer; 2016 Oct; 23(10):R437-54. PubMed ID: 27485459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary aldosteronism and pregnancy.
    Morton A
    Pregnancy Hypertens; 2015 Oct; 5(4):259-62. PubMed ID: 26597737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mineralocorticoid and apparent mineralocorticoid syndromes of secondary hypertension.
    Ardhanari S; Kannuswamy R; Chaudhary K; Lockette W; Whaley-Connell A
    Adv Chronic Kidney Dis; 2015 May; 22(3):185-95. PubMed ID: 25908467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Primary aldosteronism : Genetics and pathology].
    Scholl U
    Pathologe; 2019 Dec; 40(Suppl 3):369-372. PubMed ID: 31705237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detecting and treating primary aldosteronism: primary aldosteronism.
    Mantero F; Mattarello MJ; Albiger NM
    Exp Clin Endocrinol Diabetes; 2007 Mar; 115(3):171-4. PubMed ID: 17427105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathology of Aldosterone Biosynthesis and its Action.
    Gao X; Yamazaki Y; Tezuka Y; Omata K; Ono Y; Morimoto R; Nakamura Y; Suzuki T; Satoh F; Sasano H
    Tohoku J Exp Med; 2021 May; 254(1):1-15. PubMed ID: 34011803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetics of mineralocorticoid excess: an update for clinicians.
    Zennaro MC; Rickard AJ; Boulkroun S
    Eur J Endocrinol; 2013 Jul; 169(1):R15-25. PubMed ID: 23610123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The role of aldosterone in hypertension].
    Vonend O; Quack I; Rump LC
    Wien Klin Wochenschr; 2010 Feb; 122(3-4):65-74. PubMed ID: 20213371
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypercortisolism and primary aldosteronism caused by bilateral adrenocortical adenomas: a case report.
    Ren K; Wei J; Liu Q; Zhu Y; Wu N; Tang Y; Li Q; Zhang Q; Yu Y; An Z; Chen J; Li J
    BMC Endocr Disord; 2019 Jun; 19(1):63. PubMed ID: 31208392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cortisol Excess in Patients With Primary Aldosteronism Impacts Left Ventricular Hypertrophy.
    Adolf C; Köhler A; Franke A; Lang K; Riester A; Löw A; Heinrich DA; Bidlingmaier M; Treitl M; Ladurner R; Beuschlein F; Arlt W; Reincke M
    J Clin Endocrinol Metab; 2018 Dec; 103(12):4543-4552. PubMed ID: 30113683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Primary aldosteronism: The Mayo Clinic approach].
    Young W; Ladygina DO; Balutina OV; Beltsevich DG
    Ter Arkh; 2020 Nov; 92(10):83-87. PubMed ID: 33346484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.